Continuing its shopping spree for new protein-related technologies — and gaining another foothold in the diagnostic reagents market — Invitrogen this week said it will pay $20 million in cash to acquire Caltag Laboratories, a California manufacturer of immunological reagents.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.